Cannabis has made it’s way to top 10 most “novel and significant” research directions in Canada, with funding agencies allocating a record amount of funding to novel Cannabis studies. Take into consideration the piggy-back effect Cannabis has on the #2 most researched epidemic, that of the Opioid epidemic, and you have cannabis reaching the top of most active research topics in Canada. However, the biggest issue facing researchers is the policy of the federal government, which limit research to tracking correlation. In the US, federal law has restricted researchers ability to study any potential medical properties of cannabis. However, this might have just changed in a flash.
Aurora Cannabis & Harvard University has just announced they will both be setting up separate research collaborations in parallel within the province of Saskatchewan.
First up: Aurora Cannabis
Aurora Cannabis has officially announced its Saskatoon centre, now called Aurora Prairie, will house a new research collaboration dubbed “newest science hub” as the company expands its existing facilities and research capabilities.
“This is one of the improvements. It moves us more towards the science of cannabis, and in making sure that this facility remains a world-class, top-notch, scientific medical cannabis facility,”
said CEO Terry Booth, after he announced the rebranding to staff at the building.
Formerly known as CanniMed prior to Aurora’s takeover in 2018, the facility was Canada’s first licensed medical marijuana producer in 1988. Recently the company has contributed an estimated $4 million in upgrades since the takeover, and plans to expand significantly into 2020.The next steps for the company include completing clinical trials, strain consistency and product development.
Companies like Aurora Cannabis and institutions like Harvard University will be increasing the demand of a variety of “strains”, or rather, seed variants to grow various strains of Cannabis. They will both be looking to purchase them from Cannabis Strain research centers, that specifically modify and grow various Cannabis streams, such as CanBerry Tek, that is one of the leaders in the industry, and one that stands to benefit significantly from the increase in demand for exotic and hard to find cannabis strains. CanBerry Tek, which is owned by the Cannabis stock ticker PSIQ (Profile Solutions Inc) is a Hi-tech innovative Biotechnology Company to manage the Cannabis industries top producers with Research & Development (“R&D”) activities with the major focus on the Medical Cannabis industry and seed strain research.
This is how companies like Aurora get their researched “designed” Cannabis strains. The idea is to develop a unique man-made repository of seeds known as a Cannabis Genetic Seed Bank to create and secure rare, hard-to-find or difficult to legally obtain Cannabis seed types and varieties.
Now, Harvard University is entering Canada to pursue Cannabis Research.
Harvard University is hoping over the border to enter the world of cannabis research in a multi-million dollar partnership with a Canadian producer aimed at understanding the medicinal effects of marijuana.
Atlas Biotechnologies Inc. announced on Tuesday that it had secured a research collaboration with Harvard Global Health Catalyst at the Ivy League research university’s medical school.
The Edmonton-based company is a founding partner of the new International Phytomedicines & Medical Cannabis Institute at the school.
“It was kind of a game-changing opportunity that would allow us to not only create a collaboration with a really credible institution, but of course have access to the minds that can help us really prove the science behind the plant,”
said Atlas CEO and President Sheldon Croome.
The initial partnership will last up to three years and will focus on the effects of the drug, such as chronic pain management and other neurological conditions.